![Sheila Denton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Denton
No open positions remaining
Net worth: 3 M $ as of 2026-05-30
Profile
Sheila A. Denton worked at Boehringer Ingelheim USA, Inc. as Secretary, Senior Vice President & General Counsel.
From 2023 to 2025, served at Incyte Corp.
as Secretary, Executive VP & General Counsel.
Education includes undergraduate studies at the University of the Sacred Heart and graduate studies at Western New England University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCYTE CORPORATION 0.01% | 2025-11-16 | 26,569 ( 0.01% ) | 3 M $ | 2026-05-30 |
Former positions of Sheila Denton
| Companies | Position | End |
|---|---|---|
| INCYTE CORPORATION | General Counsel | 2025-11-30 |
Training of Sheila Denton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of the Sacred Heart
 University of the Sacred Heart Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University School of Law
 Western New England University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Sheila Denton
